首页> 外国专利> PROCESS OF SYNTHESIS OF BIOLOGICALLY IMPORTANT SEMICARBAZONES COPPER

PROCESS OF SYNTHESIS OF BIOLOGICALLY IMPORTANT SEMICARBAZONES COPPER

机译:生物学上重要的半碳杂铜的合成过程

摘要

A novel divalent macrocyclic copper (II) complexes are disclosed. The divalent copper species are directly produced by the template method with a combination of substituted carbohydrazone; tridentated semicarbazide hydrochloride and copper (II) chloride. The divalent copper (II) complexes were characterized by elemental analysis, IR, iTNMR, mass and electronic spectra.. The magnetic moments and electronic spectral studies suggested distorted octahedral geometry for all the complexes. The Cytotoxic activity against human Breast Cancer Cell line MCF-7, antibacterial- and antioxidant activities were evaluated for all synthesized compounds. The standard anti-breast cancer drug Tamoxifen was used as a positive control. The synthesized compounds were screened for their in vitro antibacterial activity using Disc Diffusion method against two strains each of gram negative and gram positive bacteria. Tetracycline was used as positive control. In-vitro antioxidant activity of all macrocyclic copper complexes was screened using the DPPH scavenging assay. All compounds showed potent antioxidant activity in the range 60-80%.
机译:公开了新颖的二价大环铜(II)配合物。二价铜种类是通过模板法与取代的碳bo的组合直接生产的;三齿氨基脲盐酸盐和氯化铜(II)。通过元素分析,IR,iTNMR,质谱和电子光谱对二价铜(II)配合物进行了表征。磁矩和电子光谱研究表明所有配合物的八面体几何形状均发生了扭曲。对于所有合成的化合物,评估了其对人乳腺癌细胞系MCF-7的细胞毒活性,抗菌和抗氧化活性。标准抗乳腺癌药物他莫昔芬用作阳性对照。使用圆盘扩散法针对革兰氏阴性菌和革兰氏阳性菌中的两种菌株筛选合成的化合物的体外抗菌活性。四环素用作阳性对照。使用DPPH清除试验筛选所有大环铜配合物的体外抗氧化活性。所有化合物均显示出有效的抗氧化活性,范围为60-80%。

著录项

  • 公开/公告号IN2015DE04258A

    专利类型

  • 公开/公告日2016-01-08

    原文格式PDF

  • 申请/专利权人

    申请/专利号IN4258/DEL/2015

  • 发明设计人 DR RICHA KOTHARI;

    申请日2015-12-23

  • 分类号A61P35/00;

  • 国家 IN

  • 入库时间 2022-08-21 14:25:04

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号